Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, January 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 134 Dimensions

Readers on

mendeley: 132 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 204,829 followers.

RT @organoidscience: In @PNASNews! By using esophageal adenocarcinoma (EAC) patient-derived cancer-associated fibroblasts, #organoid cultur…

12 Feb 2019

Reply Repost Favourite

RT @organoidscience: In @PNASNews! By using esophageal adenocarcinoma (EAC) patient-derived cancer-associated fibroblasts, #organoid cultur…

12 Feb 2019

Reply Repost Favourite

RT @organoidscience: In @PNASNews! By using esophageal adenocarcinoma (EAC) patient-derived cancer-associated fibroblasts, #organoid cultur…

12 Feb 2019

Reply Repost Favourite

In @PNASNews! By using esophageal adenocarcinoma (EAC) patient-derived cancer-associated fibroblasts, #organoid cultures & xenograft models, scientists identified IL-6 as the stromal driver of therapy resistance in EAC. https://t.co/F7OxqcNaO1 https://

12 Feb 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.